liposarcoma, dedifferentiated
Showing 1 - 5 of 5
Liposarcoma, Dedifferentiated Trial in Worldwide (BI 907828, Doxorubicin)
Recruiting
- Liposarcoma, Dedifferentiated
- BI 907828
- Doxorubicin
-
Birmingham, Alabama
- +131 more
Feb 2, 2023
Liposarcoma, Dedifferentiated Trial in New York (SPH4336)
Not yet recruiting
- Liposarcoma, Dedifferentiated
-
New York, New YorkColumbia University Medical Center
Oct 13, 2022
Liposarcoma, Myxoid, Liposarcoma, Dedifferentiated, Liposarcoma, Round Cell Trial (Trabectedin, Pioglitazone Oral Product)
Not yet recruiting
- Liposarcoma, Myxoid
- +2 more
- Trabectedin
- Pioglitazone Oral Product
- (no location specified)
Mar 10, 2021
Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)
Active, not recruiting
- Sarcoma
- +10 more
- Hypofractionated radiotherapy
- Hyperthermia
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021